IL1B and metabolic syndrome: Some studies have identified in MetS patients, the presence of some inflammatory cytokines, such as IL-1β and IL-18, which play a crucial role in the development of atherosclerotic plaques [28,29,30].Atherogenic dyslipidemia is characterized by an increase in the level of circulating triglycerides, a reduction in HDL-C levels and therefore, an increase in low-density lipoprotein cholesterol (LDL-C).